Genenta Science SpA (GNTA) is a forward-thinking clinical-stage biotechnology firm based in Milan, Italy, focused on pioneering hematopoietic stem cell gene therapies for the treatment of solid tumors. Utilizing advanced genetic engineering technologies, Genenta aims to revolutionize cancer care through its innovative, transformative therapies. The company's promising pipeline, coupled with strategic collaborations, positions it as a significant player in the oncology field, offering institutional investors a unique opportunity to engage with breakthrough advancements in biotechnology. Show more

Location: VIA OLGETTINA NO. 58, MILAN, MI, ITALY, 20132, Milan, MI, 20132, USA | Website: https://www.genenta.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

23.11M

52 Wk Range

$0.98 - $6.20

Previous Close

$1.17

Open

$1.12

Volume

328,692

Day Range

$0.98 - $1.15

Enterprise Value

15.3M

Cash

5.177M

Avg Qtr Burn

-5.515K

Insider Ownership

37.43%

Institutional Own.

10.06%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.